Chicago Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Chicago Capital Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,348	Closed	-$157K	–	32
2022 Q3	$157K	Buy	+10,348	New	+$120K	0.09%	26

Chicago Capital Management's AERI Position: Q4 2022 in Review

Chicago Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 10,348 shares — an estimated $157K sold.

Chicago Capital Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $157K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Chicago Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Chicago Capital Management sold 10,348 Aerie Pharmaceuticals shares in Q4 2022, an estimated $157K.
Chicago Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Chicago Capital Management's Aerie Pharmaceuticals position peaked at $157K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Chicago Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.